German digital health startup Oska Health has raised €11 million in seed funding to expand its hybrid care model for patients living with chronic conditions.
The round was led by Capricorn Partners and SwissHealth Ventures, with contributions from Revent, Calm Storm, LBBW Venture Capital, BMH, GoHub Ventures and Aurum Impact.
The company combines trained health coaches with artificial intelligence to provide continuous support for high-risk, chronically ill patients between clinical appointments.
Coaches work with patients via video call and chat, helping them act on physicians’ recommendations around nutrition, physical activity and medication management. A dedicated digital therapy app supports the service alongside direct coach contact.
Niklas Best, CEO and co-founder of Oska Health, said: “Chronic diseases cannot be managed in isolated doctor visits – they are decided in everyday life.
“We combine human support with AI to close this gap. Our technology supports our coaches, reduces administrative burden, and makes high-quality chronic care scalable.”
Oska Health was founded in 2022 by Best, chief product officer Claudia Ehmke and CFO and COO Dr Malte Waldeck, who between them bring experience from healthcare businesses including Fresenius Medical Care and DaVita.
The platform focuses on so-called multimorbid patients, those managing several chronic conditions simultaneously, such as chronic kidney disease, diabetes and hypertension.
Millions of people across Europe fall into this category.
The figures the company cites paint a stark picture of the challenge.
Around half of chronically ill patients do not take their medication correctly, and approximately four in five fail to sustain meaningful lifestyle changes.
In Germany, roughly 70 per cent of total healthcare expenditure is attributable to patients with chronic conditions, a proportion that continues to rise.
Oska Health’s aim is to reduce complications and avoidable hospitalisations by translating clinical advice into day-to-day practice.
Antoine D’Hollander, investment director at Capricorn Partners, said the team had built a strong track record working with health insurance funds to organise continuous care in a way that is “medically meaningful and economically sustainable.”
Markus Rommel, principal at SwissHealth Ventures, said the firm was drawn to Oska’s ability to deliver impact “where it has been least effective so far, between doctor visits.”
